Plunkett Research Online: Concordia Healthcare

CONCORDIA HEALTHCARE (CXR:TSE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Concordia International is a biotechnology company that manages, acquires, and develops drugs. The company’s operations include pharmaceutical products and orphan drugs. The product portfolio includes legacy drugs that have reached full maturity but continue to generate predictable revenue. Concordi.....



Concordia Healthcare
Ticker: CXR
Exchange: TSE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 905 842-5150
Fax: 905 842-5154
Address: 277 Lakeshore Road East
Suite 302
Oakville, ON L6J 1H9 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Allan ObermanCEO/Director
David PriceCFO
See More
Concordia International is a biotechnology company that manages, acquires, and develops drugs. The company’s operations include pharmaceutical products and orphan drugs. The product portfolio includes legacy drugs that have reached full maturity but continue to generate predictable revenue. Concordi.....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: